Verastem Statistics
Total Valuation
Verastem has a market cap or net worth of $233.10 million. The enterprise value is $137.29 million.
| Market Cap | 233.10M |
| Enterprise Value | 137.29M |
Important Dates
The next estimated earnings date is Tuesday, May 7, 2024, after market close.
| Earnings Date | May 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Verastem has 25.30 million shares outstanding. The number of shares has increased by 36.66% in one year.
| Shares Outstanding | 25.30M |
| Shares Change (YoY) | +36.66% |
| Shares Change (QoQ) | -17.68% |
| Owned by Insiders (%) | 0.57% |
| Owned by Institutions (%) | 66.78% |
| Float | 13.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 4.06 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.45, with a Debt / Equity ratio of 0.72.
| Current Ratio | 5.45 |
| Quick Ratio | n/a |
| Debt / Equity | 0.72 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -20.11 |
Financial Efficiency
Return on equity (ROE) is -127.00% and return on invested capital (ROIC) is -93.08%.
| Return on Equity (ROE) | -127.00% |
| Return on Assets (ROA) | -54.70% |
| Return on Capital (ROIC) | -93.08% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.20M |
| Employee Count | 73 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +106.89% in the last 52 weeks. The beta is 0.53, so Verastem's price volatility has been lower than the market average.
| Beta (1Y) | 0.53 |
| 52-Week Price Change | +106.89% |
| 50-Day Moving Average | 11.54 |
| 200-Day Moving Average | 9.60 |
| Relative Strength Index (RSI) | 28.46 |
| Average Volume (30 Days) | 145,296 |
Short Selling Information
The latest short interest is 806,363, so 3.19% of the outstanding shares have been sold short.
| Short Interest | 806,363 |
| Short Previous Month | 634,474 |
| Short % of Shares Out | 3.19% |
| Short % of Float | 5.89% |
| Short Ratio (days to cover) | 3.79 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -92.08M |
| Pretax Income | -87.37M |
| Net Income | -87.37M |
| EBITDA | -83.34M |
| EBIT | -83.23M |
| Earnings Per Share (EPS) | -$3.96 |
Balance Sheet
The company has $137.37 million in cash and $41.56 million in debt, giving a net cash position of $95.81 million or $3.79 per share.
| Cash & Cash Equivalents | 137.37M |
| Total Debt | 41.56M |
| Net Cash | 95.81M |
| Net Cash Per Share | $3.79 |
| Equity / Book Value | 57.37M |
| Book Value Per Share | 2.27 |
| Working Capital | 117.30M |
Cash Flow
| Operating Cash Flow | -86.46M |
| Capital Expenditures | n/a |
| Free Cash Flow | -86.46M |
| FCF Per Share | -$3.92 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Verastem does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -36.66% |
| Shareholder Yield | -36.66% |
| Earnings Yield | -37.48% |
| FCF Yield | -37.09% |
Analyst Forecast
The average price target for Verastem is $28.79, which is 212.43% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $28.79 |
| Price Target Difference | 212.43% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on June 1, 2023. It was a reverse split with a ratio of 1:12.
| Last Split Date | Jun 1, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |